iRhythm Technologies, Inc. — Director's Dealing 2020

Nov 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iRhythm Technologies, Inc. (IRTC)
CIK: 0001388658
Period of Report: 2020-11-12

Reporting Person: King Kevin M (President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-12	Common Stock	M	17918	$17	Acquired	260019	Direct
2020-11-12	Common Stock	M	1959	$8.18	Acquired	261978	Direct
2020-11-12	Common Stock	M	11792	$35.25	Acquired	273770	Direct
2020-11-12	Common Stock	S	2210	$251.8636	Disposed	271560	Direct
2020-11-12	Common Stock	S	1796	$252.4287	Disposed	269764	Direct
2020-11-12	Common Stock	S	5438	$254.4094	Disposed	264326	Direct
2020-11-12	Common Stock	S	9724	$255.1935	Disposed	254602	Direct
2020-11-12	Common Stock	S	9659	$256.1629	Disposed	244943	Direct
2020-11-12	Common Stock	S	690	$257.2528	Disposed	244253	Direct
2020-11-12	Common Stock	S	2152	$258.26	Disposed	242101	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-12	Employee Stock Option (right to buy)	$17.0	M	17918	Disposed	2026-10-19	Common Stock (17918.0)	Direct
2020-11-12	Employee Stock Option (right to buy)	$8.18	M	1959	Disposed	2025-12-15	Common Stock (1959.0)	Direct
2020-11-12	Employee Stock Option (right to buy)	$35.25	M	11792	Disposed	2027-02-16	Common Stock (11792.0)	Direct

Footnotes

F1: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.

F2: This transaction was executed in multiple trades at prices ranging from $251.20 to $251.965 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: This transaction was executed in multiple trades at prices ranging from $252.221 to $253.60 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: This transaction was executed in multiple trades at prices ranging from $253.74 to $254.73 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5: This transaction was executed in multiple trades at prices ranging from $254.75 to $255.745 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6: This transaction was executed in multiple trades at prices ranging from $255.77 to $256.55 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7: This transaction was executed in multiple trades at prices ranging from $257.22 to $257.285 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8: All of the shares subject to this option are fully vested and exercisable as of the date hereof.

F9: The option, originally granted for 100,000 shares, of which 11,792 shares have been exercised, vested as to 1/4 of the shares on March 1, 2018 and as to 1/36 of the remaining shares each month thereafter.